Company / Capital Expenditures
Korro Bio, Inc. Capital Expenditures History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$17.9M
FY2025
5-year range
$1.1M / $17.9M
FY2021-FY2025
Trend
+128.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 6 years, ranging from $1M in FY2020 to $18M in FY2025.
Based on SEC 10-K filings.
$18M in FY2025 with a 5-year CAGR of +75.9%.
Improved from $3M to $18M over the past 3 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +83.1%
- 5-Year CAGR
- +75.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +75.9%, indicating consistent growth.
- In FY2025, capital expenditures increased 128.5% year-over-year.
- Lowest capital expenditures in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.9M | +128.5% |
| FY2024 | $7.8M | +168.9% |
| FY2022 | $2.9M | -56.3% |
| FY2021 | $6.7M | +527.0% |
| FY2020 | $1.1M | -42.9% |
| FY2019 | $1.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026